Le Cong
26Patents
12h-index
42Co-inventors
77Inventor score
Filing activity: Jan 19, 2012 → Jan 26, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8993233B2 | Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains | Chemistry; Metallurgy | 490 | Active |
| US8871445B2 | CRISPR-Cas component systems, methods and compositions for sequence manipulation | Physics | 448 | Active |
| US8906616B2 | Engineering of systems, methods and optimized guide compositions for sequence manipulation | Physics | 422 | Active |
| US8999641B2 | Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains | Chemistry; Metallurgy | 407 | Active |
| US8932814B2 | CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes | Chemistry; Metallurgy | 397 | Active |
| US8614092B2 | Nucleotide-specific recognition sequences for designer TAL effectors | Chemistry; Metallurgy | 79 | Active |
| US8450107B1 | Nucleotide-specific recognition sequences for designer TAL effectors | Chemistry; Metallurgy | 78 | Active |
| US8507272B2 | Nucleotide-specific recognition sequences for designer TAL effectors | Chemistry; Metallurgy | 72 | Active |
| US8481309B2 | Nucleotide-specific recognition sequences for designer TAL effectors | Chemistry; Metallurgy | 64 | Active |
| US10577630B2 | Delivery and use of the CRISPR-Cas systems, vectors and compositions for hepatic targeting and therapy | Chemistry; Metallurgy | 48 | Active |
| US10946108B2 | Delivery, use and therapeutic applications of the CRISPR-Cas systems and compositions for targeting disorders and diseases using viral components | Chemistry; Metallurgy | 27 | Active |
| US11332719B2 | Recombinant virus and preparations thereof | Chemistry; Metallurgy | 14 | Active |
| US9370551B2 | Compositions and methods of treating head and neck cancer | Chemistry; Metallurgy | 8 | Active |
| US9499592B2 | Transcription activator-like effectors | Chemistry; Metallurgy | 8 | Active |
| US11578312B2 | Engineering and optimization of systems, methods, enzymes and guide scaffolds of CAS9 orthologs and variants for sequence manipulation | Chemistry; Metallurgy | 6 | Active |
| US11214797B2 | Assays for massively combinatorial perturbation profiling and cellular circuit reconstruction | Chemistry; Metallurgy | 3 | Active |
| US11407985B2 | Delivery, use and therapeutic applications of the CRISPR-Cas systems and compositions for genome editing | Chemistry; Metallurgy | 1 | Active |
| US12018275B2 | Delivery and use of the CRISPR-CAS systems, vectors and compositions for hepatic targeting and therapy | Chemistry; Metallurgy | 1 | Active |
| US11186825B2 | Compositions and methods for evaluating and modulating immune responses by detecting and targeting POU2AF1 | Physics | 0 | Active |
| US11312937B2 | Nucleotide-specific recognition sequences for designer TAL effectors | Chemistry; Metallurgy | 0 | Active |
| US12168789B2 | Engineering and optimization of systems, methods, enzymes and guide scaffolds of CAS9 orthologs and variants for sequence manipulation | Chemistry; Metallurgy | 0 | Active |
| US11180730B2 | Compositions and methods for evaluating and modulating immune responses by detecting and targeting GATA3 | Physics | 0 | Active |
| US11434262B2 | Transcription activator-like effectors | Chemistry; Metallurgy | 0 | Active |
| US11036670B2 | Electronic device having USB Type-C interface, control method, and readable storage | Physics | 0 | Active |
| US11996168B2 | Systems and methods for determining relative abundances of biomolecules | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.